Citius Oncology Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2024	FY 2024	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	7.3	3.92	0	0.03	-	0.29
Cash & Short-Term Investments	7.3	3.92	0	0.03	-	0.29
Cash Growth	6513695.54%	3504282.14%	-99.66%	-	-	-
Accounts Receivable	4.05	-	-	-	-	-
Inventory	22.64	22.29	8.27	-	-	-
Other Current Assets	3.16	1.33	2.7	0.03	-	0.09
Total Current Assets	37.15	27.54	10.97	0.06	7.73	0.38
Long-Term Investments	-	-	-	72.57	-	67.81
Other Long-Term Assets	72.83	73.4	73.4	-	40	-
Total Assets	109.97	100.94	84.37	72.62	47.73	68.19
Accounts Payable	10.45	13.23	3.71	-	1.29	-
Accrued Expenses	4.52	4.09	-	0.38	0.26	-
Short-Term Debt	-	-	-	1.32	-	-
Other Current Liabilities	29.74	32.16	28.99	0.35	19.5	0.03
Total Current Liabilities	44.71	49.49	32.7	2.05	21.05	0.03
Long-Term Debt	3.8	3.8	3.8	-	-	-
Other Long-Term Liabilities	3.05	2.78	1.73	-	1.15	-
Total Long-Term Liabilities	6.85	6.59	5.53	-	1.15	-
Total Liabilities	51.56	56.08	38.23	2.05	22.2	0.03
Common Stock	0.01	0.01	0.01	0	0.01	0
Additional Paid-in Capital	127.98	108.9	85.41	-	43.66	-
Retained Earnings	-69.57	-64.04	-39.28	-1.99	-18.13	0.35
Minority Interest	-	-	-	72.57	-	67.81
Shareholders' Equity	58.41	44.87	46.14	-1.99	25.54	0.35
Total Liabilities & Equity	109.97	100.94	84.37	72.62	47.73	68.19
Total Debt	3.8	3.8	3.8	1.32	0	0
Net Cash (Debt)	3.5	0.12	-3.8	-1.29	-0	0.29
Net Cash Growth	2700.82%	-	-	-	-	-
Net Cash Per Share	-	-	-0.06	-0.55	-	0.15
Book Value	58.41	44.87	46.14	-1.99	25.54	0.35
Book Value Per Share	-	-	0.68	-0.85	0.38	0.19
Tangible Book Value	58.41	44.87	46.14	-1.99	25.54	0.35
Tangible Book Value Per Share	-	-	0.68	-0.85	0.38	0.19

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q